Position in ACET
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$673,937
+$376,572 QoQ
Shares Held
78,002
+78.6% QoQ
Ownership
0.833%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 56 holders
Holding Since
Jun 2022
5 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. ACET ranks #122 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 6 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 | |
| 8 | EXEL |
Exelixis, Inc.
|
275,209 | $14,974,121 |
All Filings in ACET
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $673,937 | 78,002 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $297,365 | 43,666 | Shares | Sole | 2026-05-15 | |
| 2023-06-30 | $246,117 | 101,283 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $63,596 | 11,041 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $160,045 | 10,962 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||